-transparent.png){kind=logo}
Using a plasmid (pSWS) similar to one that has been successfully used for large-scale production of hepatitis B virus (HBV) envelope protein particles (pSVS) but containing the corresponding woodchuck hepatitis virus (WHV) envelope gene sequences, we have stably transformed the rodent dihydrofolate reductase-deficient cell line CHO dhfr-. Although production of WHV envelope particles in CHO/pSWS cell lines was low, it was sufficient to test whether these particles could bind to polymerized serum albumin. Whereas binding of HBV particles produced in CHO/pSVS cells to polymerized human serum albumin could readily be detected, we found no evidence that the WHV envelope protein particles produced in vitro bind to either human or woodchuck polymerized serum albumin.
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
January 1993,
Viral immunology,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
January 1979,
Journal of medical virology,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
October 1979,
Infection and immunity,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
January 1984,
Proceedings of the National Academy of Sciences of the United States of America,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
January 1988,
Hepatology (Baltimore, Md.),
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
March 1987,
Acta virologica,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
December 1985,
The EMBO journal,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
March 1986,
Gastroenterology,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
January 1993,
Vaccine,
B Shamoon, and
E Mandart, and
A Kay, and
F Galibert
December 1984,
Proceedings of the National Academy of Sciences of the United States of America,
